Sanitas AB (Sanitas JSC or Sanitas Group) is a Lithuania-based holding company engaged in the pharmaceutical industry. The Company's main activities include the production and sale of generic drugs, development of new products and contract manufacturing of pharmaceuticals. Its range of products comprises ampoules, tablets, ointments, injectables, eye drops, sterile powders and others. The Company’s research and development activity concentrates on the therapeutic areas of dermatology, ophthalmology, diabetology, urology, and hospital injectables. Sanitas AB operates through three wholly owned subsidiaries: Sanitas Pharma a.s. located in Slovakia, Jelfa SA and Laboratorium Farmaceutyczne Homeofarm sp. z o.o. located in Poland. In addition, it has one affiliated company, Valeant IPM sp. z o.o. As of December 31, 2011, the Company’s major shareholder was Valeant Pharmaceuticals International, Inc. with a stake of 99.4%.